[go: up one dir, main page]

HUP0101498A1 - Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására - Google Patents

Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására

Info

Publication number
HUP0101498A1
HUP0101498A1 HU0101498A HUP0101498A HUP0101498A1 HU P0101498 A1 HUP0101498 A1 HU P0101498A1 HU 0101498 A HU0101498 A HU 0101498A HU P0101498 A HUP0101498 A HU P0101498A HU P0101498 A1 HUP0101498 A1 HU P0101498A1
Authority
HU
Hungary
Prior art keywords
dexmedetomidine
pharmaceutical compositions
sedative effect
producing pharmaceutical
producing
Prior art date
Application number
HU0101498A
Other languages
English (en)
Inventor
Ricu Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Abbott Laboratories
Orion Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0101498(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories, Orion Corp. filed Critical Abbott Laboratories
Publication of HUP0101498A1 publication Critical patent/HUP0101498A1/hu
Publication of HUP0101498A3 publication Critical patent/HUP0101498A3/hu
Publication of HU229162B1 publication Critical patent/HU229162B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya (I) képletű dexmedetomidin vagy ennekfarmakológiailag alkalmazható sója alkalmazása intenzív osztályonnyugtatószerként alkalmazható gyógyszerkészítmények előállítására. Ó
HU0101498A 1998-04-01 1999-03-31 Dexmedetomidin nyugtatószerként történõ alkalmazása intenzív osztályon HU229162B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (3)

Publication Number Publication Date
HUP0101498A1 true HUP0101498A1 (hu) 2002-03-28
HUP0101498A3 HUP0101498A3 (en) 2002-06-28
HU229162B1 HU229162B1 (hu) 2013-09-30

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101498A HU229162B1 (hu) 1998-04-01 1999-03-31 Dexmedetomidin nyugtatószerként történõ alkalmazása intenzív osztályon

Country Status (27)

Country Link
EP (1) EP1069893B1 (hu)
JP (1) JP4606581B2 (hu)
KR (1) KR20010034728A (hu)
CN (1) CN1168441C (hu)
AR (1) AR015744A1 (hu)
AT (1) ATE347359T1 (hu)
AU (1) AU754484B2 (hu)
BG (1) BG64540B1 (hu)
BR (1) BR9909872A (hu)
CA (1) CA2326339C (hu)
CZ (1) CZ301013B6 (hu)
DE (1) DE69934305T2 (hu)
DK (1) DK1069893T3 (hu)
EA (1) EA005524B1 (hu)
ES (1) ES2278441T3 (hu)
GB (1) GB2352972B (hu)
HU (1) HU229162B1 (hu)
IL (1) IL138416A (hu)
NO (1) NO329194B1 (hu)
NZ (1) NZ507203A (hu)
PL (1) PL192517B1 (hu)
PT (1) PT1069893E (hu)
SI (1) SI1069893T1 (hu)
SK (1) SK286160B6 (hu)
TR (1) TR200002837T2 (hu)
TW (1) TW552136B (hu)
WO (1) WO1999049854A2 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2259827C2 (ru) 1999-10-29 2005-09-10 Орион Корпорейшн Лечение или предупреждение гипотензии и шока
CA2480881C (en) * 2002-04-08 2012-09-11 Guilford Pharmaceuticals, Inc. Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
US20080119820A1 (en) 2006-09-20 2008-05-22 Phan Phillip C Methods for Delivering Volatile Anesthetics for Regional Anesthesia and/or Pain Relief
CA2712731C (en) 2008-01-22 2016-05-03 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
JP6172938B2 (ja) * 2009-05-15 2017-08-02 レクロ・ファーマ，インコーポレーテッド デクスメデトミジンの舌下組成物およびその使用方法
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
PE20142314A1 (es) 2011-12-11 2015-01-23 Recro Pharma Inc Composiciones intranasales de dexmedetomidina y metodos de uso de ellas
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
KR102146690B1 (ko) * 2012-10-15 2020-08-24 오리온 코포레이션 수의학적 소음 혐오증 완화 방법
CN105473669A (zh) 2013-07-24 2016-04-06 I-技术有限公司 作为抑制剂的对映异构体左旋美托咪啶在海洋生物污损表面附着的应用
JP6310070B2 (ja) 2013-10-07 2018-04-11 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を用いる、注意欠陥多動性障害、不安症及び不眠症の治療法及び組成物
US10987342B2 (en) * 2013-10-07 2021-04-27 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
RU2723761C1 (ru) 2016-10-31 2020-06-17 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы устранения боли с использованием устройств для трансдермальной доставки дексмедетомидина
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法
CN115197149B (zh) * 2021-04-02 2023-09-22 四川大学华西医院 一种5-苄基咪唑类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
DE69934305T2 (de) 2007-07-12
HU229162B1 (hu) 2013-09-30
ATE347359T1 (de) 2006-12-15
JP4606581B2 (ja) 2011-01-05
IL138416A0 (en) 2001-10-31
AU3149499A (en) 1999-10-18
EA200001010A1 (ru) 2001-02-26
CA2326339A1 (en) 1999-10-07
AU754484B2 (en) 2002-11-14
TR200002837T2 (tr) 2001-01-22
KR20010034728A (ko) 2001-04-25
WO1999049854A3 (en) 1999-11-18
TW552136B (en) 2003-09-11
GB0024932D0 (en) 2000-11-29
SK14362000A3 (sk) 2002-03-05
DK1069893T3 (da) 2007-03-19
AR015744A1 (es) 2001-05-16
EP1069893A2 (en) 2001-01-24
CN1168441C (zh) 2004-09-29
NO20004931D0 (no) 2000-09-29
GB2352972B (en) 2003-05-21
SI1069893T1 (sl) 2007-04-30
WO1999049854A2 (en) 1999-10-07
CA2326339C (en) 2008-12-23
PL192517B1 (pl) 2006-10-31
SK286160B6 (sk) 2008-04-07
GB2352972A (en) 2001-02-14
CZ301013B6 (cs) 2009-10-14
ES2278441T3 (es) 2007-08-01
DE69934305D1 (de) 2007-01-18
BG64540B1 (bg) 2005-07-29
PT1069893E (pt) 2007-01-31
NZ507203A (en) 2003-03-28
PL343553A1 (en) 2001-08-27
HUP0101498A3 (en) 2002-06-28
IL138416A (en) 2005-07-25
CZ20003484A3 (cs) 2002-01-16
BG104797A (en) 2001-07-31
EP1069893B1 (en) 2006-12-06
NO20004931L (no) 2000-09-29
BR9909872A (pt) 2007-11-20
JP2002509880A (ja) 2002-04-02
CN1295473A (zh) 2001-05-16
EA005524B1 (ru) 2005-04-28
NO329194B1 (no) 2010-09-13

Similar Documents

Publication Publication Date Title
HUP0101498A1 (hu) Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
SE0101387D0 (sv) Novel compounds
DE69925133D1 (de) Pyrrolobenzodiazepine
SE0001899D0 (sv) New compounds
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
CO5590918A2 (es) Formulaciones
ATE475650T1 (de) Positive allosterische chinolon-m1- rezeptormodulatoren
DK1051155T3 (da) Nasale opløsninger
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
TNSN04165A1 (en) Substituted hydroxyethylamines
DE60045508D1 (de) Dalda-analoge und ihre verwendung
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
BG106155A (en) Novel derivatives and analogues of galanthamin
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE9801494D0 (sv) Novel use
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ATE360428T1 (de) Analgetisches arzneimittel
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ORION CORPORATION, FI

Free format text: FORMER OWNER(S): ORION CORP., FI

Owner name: ABBOTT LABORATORIES, US

Free format text: FORMER OWNER(S): ORION CORP., FI

GB9A Succession in title

Owner name: ORION CORPORATION, FI

Free format text: FORMER OWNER(S): ORION CORP., FI; ABBOTT LABORATORIES, US; ORION CORPORATION, FI